- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.03. | POSITRON CORP - 10-K, Annual Report | - | SEC Filings | ||
| 17.02. | Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives | 208 | GlobeNewswire (Europe) | Buffalo, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the "Company"), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET)... ► Artikel lesen | |
| 30.12.25 | POSITRON CORP - 8-K, Current Report | - | SEC Filings | ||
| POSITRON Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | POSITRON CORP - 8-K, Current Report | - | SEC Filings | ||
| 17.11.25 | Positron Corporation Announces Its Transition to a Reporting SEC Company | 231 | GlobeNewswire (Europe) | Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BUTTERFLY NETWORK | 4,435 | 0,00 % | Butterfly Network wins FDA clearance for gestational age AI ultrasound tool | ||
| VYOME | 2,280 | +0,44 % | Vyome to present VT-1953 Phase 2 data at cancer research meeting | ||
| DIAGNOSTEAR TECHNOLOGIES | 0,214 | +25,88 % | Im Fokus der Anleger: Klinische Zulassungsstudien in Frankreich gestartet! | ||
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| HEARTFLOW | 29,020 | +5,68 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | +5,34 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | +11,04 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,120 | +0,43 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| LIFESTANCE HEALTH GROUP | 6,510 | +0,70 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | +1,78 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| SIGHT SCIENCES | 3,820 | +3,52 % | Sight Sciences, Inc.: Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| CERIBELL | 19,550 | +2,25 % | Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results | SUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |
Das Unternehmen POSITRON CORP kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POSITRON CORP finden Sie auf Wallstreet Online.